Results 221 to 230 of about 14,856,428 (285)

Peripheral T-cell lymphoma of the lip: a rare case unveiling key insights into diagnosis and management. [PDF]

Ecancermedicalscience
Ali T, Khan L, Qureshi BM, Hafiz A, Tariq M, Minhas K, Ali N, Abbasi AN.   +7 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

USP1-TRAF2 axis-regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma. [PDF]

Proc Natl Acad Sci U S A
Gui A, Yan Y, Jiang S, Chen F, Zhou X, Sun Q, Qiu S, Wu J, Li X, Zhang J, Liu J, Zhu S, Wang L, Liu W, Zuo J, Zhang Q, Yang L.   +16 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy. [PDF]

Int J Hematol
Tatetsu H, Kato K, Wada A, Hirano T, Ueno S, Miyasato Y, Yamada A, Shichijo T, Higuchi Y, Ueda Y, Nosaka K, Mikami Y, Karube K, Matsuoka M, Yasunaga JI.   +14 more
europepmc   +1 more source

A comprehensive review of cancer‐induced cardiac wasting

British Journal of Pharmacology, EarlyView.
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena, Muhammad Shahzeb Khan, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Markus S. Anker   +5 more
wiley   +1 more source

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup. [PDF]

Sci Adv
Lone WG, Yu J, Liu X, Jochum DT, Bouska A, Shetty K, Herek T, Sharma S, Bi C, Shah R, Nasser ZW, Amador C, Arif A, Mir AR, Li Y, Heavican-Foral TB, Robinson J, Hyde RK, Sakata-Yanagimoto M, Rachagani S, McKeithan TW, Scott DW, Staudt LM, Inghirami G, Feldman A, Greiner T, Vose JM, Rimsza L, Khoury J, Chan WC, Iqbal J, Lymphoma/Leukemia Molecular Profiling Project (LLMPP).   +31 more
europepmc   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma. [PDF]

Blood Adv
Iyer S, Mehta-Shah N, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Alpdogan O, Feldman TA, Camus V, Gritti G, Zinzani PL, Belada D, Mayer J, Choi I, Cheong JW, Rustia E, Fenton K, Fanale M, Savage KJ, Horwitz SM.   +22 more
europepmc   +1 more source

Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival. [PDF]

Br J Haematol
Partanen A, Rönkä A, Anttalainen A, Ukkola-Vuoti L, Toppila I, Kuitunen H, Miettinen T, Kuittinen O.   +7 more
europepmc   +1 more source